ORTIN GLOBAL DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.01×	1.02×	1.01×	1.14×	0.80×
	0.76×	0.70×	0.94×	1.05×	−0.31×
	−1,619.8%	−1,030.5%	−261.6%	−320.4%	4.5%
	0.02×	0.02×	0.07×	0.15×	0.28×
	3.76×	3.76×	1.91×	2.33×	1.95×
	−93.8%	−55.3%	−33.1%	−133.3%	−0.6%
	−46.1%	−46.1%	−35.3%	−117.5%	−0.6%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ORTINGLOBE₹13.13

ORTIN GLOBAL LIMITED

· Pharma & Health

₹ CrorePeersLASA MANGALAM BIOFILCHEM VINEETLAB KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹10.7 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.80	1.14	1.01	1.02	1.01
Interest Burden (Pretax/EBIT) ×	-0.31	1.05	0.94	0.70	0.76
EBIT Margin %	4.49	-320.41	-261.63	-1,030.55	-1,619.78
Asset Turnover ×	0.28	0.15	0.07	0.02	0.02
Financial Leverage (Assets/Equity) ×	1.95	2.33	1.91	3.76	3.76
ROE (5-step product, year-end total equity) %	-0.61	-133.31	-33.10	-55.35	-93.82
ROE (owners' profit / average owners' equity) %	-0.62	-117.48	-35.26	-46.06	-46.06

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.